CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Darya-Varia Laboratoria Tbk PT is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Darya-Varia Laboratoria Tbk PT
Lantai 8-10, Talavera Office Park
Jl. Letjen T.B. Simatupang Kav. 22-26
Phone: +62 2122768000p:+62 2122768000 JAKARTA SELATAN, 12430  Indonesia Ticker: DVLADVLA
Business Summary
PT Darya-Varia Laboratoria Tbk is an Indonesia-based pharmaceutical company. Its segments include prescription drugs, consumer health products, export and toll manufacturing services and services. Its consumer health products include skin nutrition, respiratory, vitamins and daily relief. Its prescription products include Daryaven, Urdafalk and Aspilets. Through its multivitamin brands, such as Enervon-C, Enervon Active, Enervon Gold and Supertin, it helps to boost body immune and maintain health. It also provides Imunped as a supplement for kids with Zinc and vitamin C, which are essential for children. Its Forti-D 1000 IU is a health supplement (vitamin) product. Fortagyl provides prevention and treatment of amoebiasis, trichomoniasis, giardiasis and post-operation infections. It provides toll manufacturing services for both local and international principals with its two manufacturing facilities: Gunung Putri and Citeureup manufacturing facilities.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President Commissioner Clinton Andrew C.Hess 51 6/11/2019 6/30/2005
President Director Jose SumpaicoRomana 60 10/20/2020 1/26/2015
Vice President Commissioner Eric Albert L.Gotuaco 54 6/11/2019 6/30/2006
9 additional Officers and Directors records available in full report.

Business Names
Business Name
DVLA
PT Darya-Varia Laboratoria
PT Darya-Varia Laboratoria Tbk

General Information
Number of Employees: 1,266 (As of 9/30/2024)
Outstanding Shares: 1,120,000,000 (As of 9/30/2024)
Shareholders: 1,944
Stock Exchange: JAK
Fax Number: +62 2122768016


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024